FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079061625> ?p ?o ?g. }

• W2079061625 endingPage "8188" @default.
• W2079061625 startingPage "8180" @default.
• W2079061625 abstract "The interferon antiviral system is a primary barrier to virus replication triggered upon recognition of nonself RNAs by the cytoplasmic sensors encoded by retinoic acid-inducible gene I (RIG-I), melanoma differentiation-associated gene 5 (MDA5), and laboratory of genetics and physiology gene 2 (LGP2). Paramyxovirus V proteins are interferon antagonists that can selectively interact with MDA5 and LGP2 through contact with a discrete helicase domain region. Interaction with MDA5, an activator of antiviral signaling, disrupts interferon gene expression and antiviral responses. LGP2 has more diverse reported roles as both a coactivator of MDA5 and a negative regulator of both RIG-I and MDA5. This functional dichotomy, along with the concurrent interference with both cellular targets, has made it difficult to assess the unique consequences of V protein interaction with LGP2. To directly evaluate the impact of LGP2 interference, MDA5 and LGP2 variants unable to be recognized by measles virus and parainfluenza virus 5 (PIV5) V proteins were tested in signaling assays. Results indicate that interaction with LGP2 specifically prevents coactivation of MDA5 signaling and that LGP2's negative regulatory capacity was not affected. V proteins only partially antagonize RIG-I at high concentrations, and their expression had no additive effects on LGP2-mediated negative regulation. However, conversion of RIG-I to a direct V protein target was accomplished by only two amino acid substitutions that allowed both V protein interaction and efficient interference. These results clarify the unique consequences of MDA5 and LGP2 interference by paramyxovirus V proteins and help resolve the distinct roles of LGP2 in both activation and inhibition of antiviral signal transduction. Importance: Paramyxovirus V proteins interact with two innate immune receptors, MDA5 and LGP2, but not RIG-I. V proteins prevent MDA5 from signaling to the beta interferon promoter, but the consequences of LGP2 targeting are poorly understood. As the V protein targets MDA5 and LGP2 simultaneously, and LGP2 is both a positive and negative regulator of both MDA5 and RIG-I, it has been difficult to evaluate the specific advantages conferred by LGP2 targeting. Experiments with V-insensitive proteins revealed that the primary outcome of LGP2 interference is suppression of its ability to synergize with MDA5. LGP2's negative regulation of MDA5 and RIG-I remains intact irrespective of V protein interaction. Complementary experiments demonstrate that RIG-I can be converted to V protein sensitivity by two amino acid substitutions. These findings clarify the functions of LGP2 as a positive regulator of MDA5 signaling, demonstrate the basis for V-mediated LGP2 targeting, and broaden our understanding of paramyxovirus-host interactions." @default.
• W2079061625 created "2016-06-24" @default.
• W2079061625 creator A5009824810 @default.
• W2079061625 creator A5050207807 @default.
• W2079061625 date "2014-07-15" @default.
• W2079061625 modified "2023-10-14" @default.
• W2079061625 title "Paramyxovirus V Protein Interaction with the Antiviral Sensor LGP2 Disrupts MDA5 Signaling Enhancement but Is Not Relevant to LGP2-Mediated RLR Signaling Inhibition" @default.
• W2079061625 cites W1966759986 @default.
• W2079061625 cites W1983921697 @default.
• W2079061625 cites W1989960436 @default.
• W2079061625 cites W1992109232 @default.
• W2079061625 cites W1994845424 @default.
• W2079061625 cites W2000871561 @default.
• W2079061625 cites W2010057180 @default.
• W2079061625 cites W2011507014 @default.
• W2079061625 cites W2018739763 @default.
• W2079061625 cites W2026227217 @default.
• W2079061625 cites W2028575270 @default.
• W2079061625 cites W2032980461 @default.
• W2079061625 cites W2038630105 @default.
• W2079061625 cites W2046900681 @default.
• W2079061625 cites W2065554630 @default.
• W2079061625 cites W2066425910 @default.
• W2079061625 cites W2068551986 @default.
• W2079061625 cites W2089941298 @default.
• W2079061625 cites W2093755635 @default.
• W2079061625 cites W2100665873 @default.
• W2079061625 cites W2101525702 @default.
• W2079061625 cites W2105110692 @default.
• W2079061625 cites W2110193364 @default.
• W2079061625 cites W2117735867 @default.
• W2079061625 cites W2125566625 @default.
• W2079061625 cites W2127096990 @default.
• W2079061625 cites W2136329789 @default.
• W2079061625 cites W2138553385 @default.
• W2079061625 cites W2141425521 @default.
• W2079061625 cites W2144877088 @default.
• W2079061625 cites W2147093282 @default.
• W2079061625 cites W2147728007 @default.
• W2079061625 cites W2150170466 @default.
• W2079061625 cites W2152433346 @default.
• W2079061625 cites W2153342952 @default.
• W2079061625 cites W2159685069 @default.
• W2079061625 cites W2159846280 @default.
• W2079061625 cites W2162250600 @default.
• W2079061625 cites W2170063337 @default.
• W2079061625 doi "https://doi.org/10.1128/jvi.00737-14" @default.
• W2079061625 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4097766" @default.
• W2079061625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24829334" @default.
• W2079061625 hasPublicationYear "2014" @default.
• W2079061625 type Work @default.
• W2079061625 sameAs 2079061625 @default.
• W2079061625 citedByCount "35" @default.
• W2079061625 countsByYear W20790616252014 @default.
• W2079061625 countsByYear W20790616252015 @default.
• W2079061625 countsByYear W20790616252016 @default.
• W2079061625 countsByYear W20790616252017 @default.
• W2079061625 countsByYear W20790616252018 @default.
• W2079061625 countsByYear W20790616252019 @default.
• W2079061625 countsByYear W20790616252020 @default.
• W2079061625 countsByYear W20790616252021 @default.
• W2079061625 countsByYear W20790616252022 @default.
• W2079061625 countsByYear W20790616252023 @default.
• W2079061625 crossrefType "journal-article" @default.
• W2079061625 hasAuthorship W2079061625A5009824810 @default.
• W2079061625 hasAuthorship W2079061625A5050207807 @default.
• W2079061625 hasBestOaLocation W20790616251 @default.
• W2079061625 hasConcept C104317684 @default.
• W2079061625 hasConcept C134474686 @default.
• W2079061625 hasConcept C159047783 @default.
• W2079061625 hasConcept C166703698 @default.
• W2079061625 hasConcept C2776178377 @default.
• W2079061625 hasConcept C2776954689 @default.
• W2079061625 hasConcept C54355233 @default.
• W2079061625 hasConcept C62478195 @default.
• W2079061625 hasConcept C67705224 @default.
• W2079061625 hasConcept C86803240 @default.
• W2079061625 hasConcept C95444343 @default.
• W2079061625 hasConceptScore W2079061625C104317684 @default.
• W2079061625 hasConceptScore W2079061625C134474686 @default.
• W2079061625 hasConceptScore W2079061625C159047783 @default.
• W2079061625 hasConceptScore W2079061625C166703698 @default.
• W2079061625 hasConceptScore W2079061625C2776178377 @default.
• W2079061625 hasConceptScore W2079061625C2776954689 @default.
• W2079061625 hasConceptScore W2079061625C54355233 @default.
• W2079061625 hasConceptScore W2079061625C62478195 @default.
• W2079061625 hasConceptScore W2079061625C67705224 @default.
• W2079061625 hasConceptScore W2079061625C86803240 @default.
• W2079061625 hasConceptScore W2079061625C95444343 @default.
• W2079061625 hasIssue "14" @default.
• W2079061625 hasLocation W20790616251 @default.
• W2079061625 hasLocation W20790616252 @default.
• W2079061625 hasLocation W20790616253 @default.
• W2079061625 hasLocation W20790616254 @default.
• W2079061625 hasOpenAccess W2079061625 @default.
• W2079061625 hasPrimaryLocation W20790616251 @default.
• W2079061625 hasRelatedWork W1965250565 @default.
• W2079061625 hasRelatedWork W1992680762 @default.

• next